Covid-19 Diagnostics Market to Surpass $17,20 Billion : What's Driving the Industry?

The Global Covid-19 diagnostics industry was pegged at $73.19 million in the first quarter of 2020, and is projected to reach $9.94 billion by the fourth quarter of 2020.

The COVID-19 diagnostics market refers to the market for tests and diagnostic tools used to detect the presence of the SARS-CoV-2 virus, which causes the COVID-19 disease. These diagnostics are essential for identifying individuals who are infected with the virus and initiating appropriate measures to control its spread.

Since the emergence of the COVID-19 pandemic, the global diagnostics market has experienced significant growth and innovation. Various types of tests have been developed and deployed worldwide, ranging from traditional laboratory-based tests to rapid point-of-care tests. The diagnostics market includes both molecular tests (such as PCR-based tests) and serological tests (such as antibody tests).

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.alliedmarketresearch.com/request-sample/6479

𝐃𝐫𝐢𝐯𝐞𝐫𝐬, 𝐫𝐞𝐬𝐭𝐫𝐚𝐢𝐧𝐭𝐬, 𝐚𝐧𝐝 𝐨𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬

Rise in Covid-19 patients across the world, need for rapid diagnostics, and lack of specific vaccine or medicine drive the growth of the global Covid-19 diagnostics market. However, lack of awareness among developing countries regarding precautions and dearth of diagnostic kits & medical professionals hinder the market growth. On the contrary, development of advanced diagnostic kits would open new opportunities for the market players in the future.

𝐖𝐡𝐚𝐭 𝐢𝐬 𝐭𝐡𝐞 𝐢𝐦𝐩𝐚𝐜𝐭 𝐨𝐟 𝐂𝐨𝐯𝐢𝐝-𝟏𝟗 𝐨𝐧 𝐂𝐨𝐯𝐢𝐝-𝟏𝟗 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐥𝐨𝐛𝐚𝐥𝐥𝐲?

Researchers have been focused on developing a potential treatment for Covid-19 and have been conducting months of trials to find the cure, which increased the demand for Covid-19 diagnostic tools.
Since the outbreak of Covid-19, researchers have been working to develop more accurate and faster diagnostic kits.

𝐏𝐫𝐨𝐜𝐮𝐫𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 (𝟐𝟐𝟎 𝐏𝐚𝐠𝐞𝐬 𝐏𝐃𝐅 𝐰𝐢𝐭𝐡 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬, 𝐂𝐡𝐚𝐫𝐭𝐬, 𝐓𝐚𝐛𝐥𝐞𝐬, 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬): https://www.alliedmarketresearch.com/checkout-final/d5f0b613897948deaf0203915862c823

𝐓𝐡𝐞 𝐏𝐂𝐑 𝐤𝐢𝐭𝐬 𝐬𝐞𝐠𝐦𝐞𝐧𝐭 𝐡𝐞𝐥𝐝 𝐭𝐡𝐞 𝐥𝐚𝐫𝐠𝐞𝐬𝐭 𝐬𝐡𝐚𝐫𝐞

By product, the PCR kits segment held the lion's share in the first quarter of 2020, and is expected to maintain its dominance till the end of 2020. This is due to their high accuracy and specificity. The global Covid-19 diagnostics market report includes an analysis of other segments such as POC kits and Immunoassay.

𝐓𝐡𝐞 𝐝𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜 𝐥𝐚𝐛𝐬 𝐬𝐞𝐠𝐦𝐞𝐧𝐭 𝐝𝐨𝐦𝐢𝐧𝐚𝐭𝐞𝐝 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭

By end user, the diagnostic labs segment held the largest share in the first quarter of 2020, contributing to more than two-thirds of the global Covid-19 diagnostics market, due to increased usage of molecular assays for Covid-19 diagnosis as the procedure requires various chemicals and instruments that are more easily available in a diagnostic laboratory. The report includes an analysis of other segments such as hospitals and physician offices & urgent care clinics.

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐞: https://www.alliedmarketresearch.com/purchase-enquiry/6479

𝐄𝐮𝐫𝐨𝐩𝐞, 𝐟𝐨𝐥𝐥𝐨𝐰𝐞𝐝 𝐛𝐲 𝐀𝐬𝐢𝐚-𝐏𝐚𝐜𝐢𝐟𝐢𝐜 𝐚𝐧𝐝 𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚, 𝐡𝐞𝐥𝐝 𝐭𝐡𝐞 𝐥𝐢𝐨𝐧'𝐬 𝐬𝐡𝐚𝐫𝐞

By region, the market across Asia-Pacific is expected to contribute the highest revenue by the fourth quarter of end of 2020, owing to a higher number of patient populations in this region. The global Covid-19 diagnostics market across Europe held the lion's share in the first quarter of 2020, contributing to nearly half of the total revenue.

𝐂𝐨𝐯𝐢𝐝-𝟏𝟗 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:

Seegene Inc.,
Robert Bosch GmbH
Cellex Inc.
F. Hoffmann-La Roche AG
Cepheid
MylabLifesolutions Pvt. Ltd.
Thermo Fisher Scientific, Inc.
Genematrix
SureScreen Diagnostics Ltd.

𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲:

Gene Synthesis Market: https://www.alliedmarketresearch.com/gene-synthesis-market-A39015

Mobile Tomography Market: https://www.alliedmarketresearch.com/mobile-tomography-market-A31901

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐮𝐬:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.